Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/10/2003CN1441675A Compositions and methods for achieving immune suppression
09/10/2003CN1441058A Prepn process of gene recombining salmon calcitonin
09/10/2003CN1441057A Construction method of recombinant DNA expressing epidermal growth factor in animal's mammary gland
09/10/2003CN1441056A Combined mutant of histotypic plasminogen activator
09/10/2003CN1440983A Human thymosin alpha-protothymulin fusion protein and its prepn and use
09/10/2003CN1440982A Construction process of recombinant DNA expressing fibroblast growth factor (FGF) inside animal mammary gland
09/10/2003CN1440981A New-type recombinant tissue factor inhibiting peptide and its prepn and application
09/10/2003CN1440814A Specific HIV RNA degrading agent and its prepn
09/10/2003CN1120888C Plant expression carrier with dual insect-resistant genes and its application
09/10/2003CN1120887C Process for preparing bio-degradable plastics by construction of genetically engineering cytoalgae
09/09/2003US6617498 Linked to nucleotide sequence of isolated nucleic acid; incorporating into cell genome and regenerating a stably transormed plant; regulates transcription by inducing expression in response to a stimulus
09/09/2003US6617497 Transformed plant comprising a nucleic acid encoding a protein that exhibits enzymatic activity; can use to alter pathogen resistance and plant growth properties
09/09/2003US6617496 Agrobacterium-mediated transformation of cells by introducing a chimeric DNA sequence which causes transcription; hybridization to inhibit pathogenicity; generating mature plants which confer the desired traits
09/09/2003US6617495 Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis
09/09/2003US6617494 Methods for identifying transgenic plants using morphological markers
09/09/2003US6617493 Nucleotide sequence encoding soybean vestitone reductase
09/09/2003US6617492 Screening a plant to determine whether it is a hybrid by isolating genomic DNA, digesting with a restriction enzyme, probing with a DNA marker; resistance to insects/diseases, drought/stress/cold tolerance, perennialism, quality
09/09/2003US6617450 P-glycoproteins and uses thereof
09/09/2003US6617445 Asymmetric benzoxanthene dye for use as signaling tools in nucleotide sequence analysis
09/09/2003US6617443 From nucleic acids; pre-incubating the nucleic acids in a salt-free detergent solution and subsequent anion exchange chromatography on a tentacle anion exchanger, especially one containing glycidyl methacrylate units
09/09/2003US6617442 Human Rnase H1 and oligonucleotide compositions thereof
09/09/2003US6617440 Isolated polynucleotide that promotes transcription; gene expression inhibition; used for engineering animals with increased lean meat and promoting muscle growth; treating muscular disorders
09/09/2003US6617438 Nucleic acid of given formula; ribozyme able to cleave RNA of HER2 gene; use as anticarcinogenic agent
09/09/2003US6617437 Modified oligonucleotide of given formula; useful in diagnostics and therapeutics
09/09/2003US6617435 Infiltrating a plant tissue with a buffer solution; subjecting plant tissue and buffer solution to a substantially vacuum environment; removing tissue from the buffer solution; centrifuging the tissue to remove interstitial fluid;
09/09/2003US6617433 Of given amino acid sequence; can use for gene expression
09/09/2003US6617432 Useful as markers in diagnosing, monitoring the stage of malignancy and treating prostate cancer
09/09/2003US6617431 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
09/09/2003US6617430 Ataxin-2 binding proteins
09/09/2003US6617429 Apoptosis inhibitory protein, gene encoding the protein and cDNA thereof
09/09/2003US6617428 Immunoglobulin M(IgM); given amino acid sequence; immunomodulators; use in blocking or inhibiting humoral immune responses in transplant patients
09/09/2003US6617427 Capable of promoting tumor necrosis factor induced apoptosis; useful as targets for screening drugs that regulate-cell cycle progression and apoptosis; use in treating degenerative diseases and cancer
09/09/2003US6617424 Undecapeptides containing cysteinesulfinic and cysteinesulfenic acid
09/09/2003US6617422 Peptide nucleic acid monomers and oligomers
09/09/2003US6617312 Contains a sequence motif selected from the group consisting of the motifs (Asp or Glu)-Ala-Trp-(Lys or Arg) or (Tyr or Cys)-(Glu or Asp)-(Leu or Ile)-Trp; binds to vasoactive amines such as histamine
09/09/2003US6617163 Polynucleotides for mutagenesis in fungus comprising a functional gene in magnaporthe and an impala transposon
09/09/2003US6617162 Antisense modulation of estrogen receptor alpha expression
09/09/2003US6617156 Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
09/09/2003US6617148 Generation of preferential protein in sample; obtain bacillus, transform, express vector, recover protein
09/09/2003US6617147 Nucleotide sequences coding polypeptides for use in human therapeutics and diagnostics
09/09/2003US6617145 Enzymatic protein for use in treatment of thrombosis
09/09/2003US6617139 Isolated protein of given sequence; stereoselectively hydrolyzes alpha -amino acid amides and alpha -hydroxy acid amides
09/09/2003US6617138 Nucleic acid detection method
09/09/2003US6617136 Comprises polymerase or a ligase and near-infrared diiminium dye or cyanine dye; amplification
09/09/2003US6617135 Multiple cytokine protein complexes
09/09/2003US6617134 Dimer of molecular variant of apolipoprotein and processes for the production thereof
09/09/2003US6617132 Nucleotide sequences which code polypeptide for use in treating osteoporosis, tumor metastasis, microbial infections, viral infection, sepsis, inflammation, vision defects, cachicia and muscle disorders
09/09/2003US6617130 Cyanophage or cyanobacteria promoter; vectors
09/09/2003US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer
09/09/2003US6617128 Nucleotide sequences coding proteins for use in prevention of bacteria infection; for use in treatment of gonorrhea
09/09/2003US6617122 Contacting a compound with a polypeptide, in the presence of adenosine triphosphate (ATP) and detecting its binding or hydrolysis of ATP; use in treatment of coronary artery disease
09/09/2003US6617120 Nuclear receptor for use as tool in human therapeutics and diagnostics
09/09/2003US6617117 MAP kinases: polypeptides, polynucleotides and uses thereof
09/09/2003US6617113 Methods of determining the presence of double stranded nucleic acids in a sample
09/09/2003US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent
09/09/2003US6617108 Using polypeptides, polyamines, trivalent and tetravalent metal ions to a lysate containing DNA; purification of plasmid DNA without the use of nucleases or proteases or organic solvent extraction
09/09/2003US6617106 Methods for preparing oligonucleotides containing non-standard nucleotides
09/09/2003US6617105 Binding cells in sample onto a solid support, lysing the isolated cells and binding them to another solid support; use in many biochemical and diagnostic procedures
09/09/2003US6617103 Detecting the presence of hybridized nucleic acid; use for diagnosis and treatment of genital cancer
09/09/2003US6617102 Screening for a bioactive agent capable of interfering with the binding of a protein; use in diagnosis and treatment of cancer
09/09/2003US6616930 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method
09/09/2003US6616929 Expression vector consisting of the nucleotide sequence of pCI(* Delta XbaI)/SVDV-T(XbaI), excluding any sequence that encodes any P-1 region.
09/09/2003US6616824 Apparatus for electrophoresis
09/09/2003CA2213731C Methods and reagents for typing hla class i genes
09/09/2003CA2145630C Microorganisms for the production of tryptophan and process for producing the same
09/07/2003WO2003074701A1 p18AβrP GENE AND p18AβrP PROTEIN, NOVEL GENE/PROTEIN (p60TRP) INTERACTING THEREWITH TO INHIBIT CELL DEATH AND CELL DEATH PROMOTER
09/07/2003CA2432937A1 P18abrp gene and p18abrp protein, and novel gene/protein (p60trp) suppressing cell death and substances promoting cell death by interaction with the same
09/06/2003CA2420829A1 Novel fusion protein of human igg1 heavy chain constant region and scfv antibody against venezuelan equine encephalitis virus
09/05/2003CA2374527A1 Gene of enzyme activity to generate lachrymatory factor
09/04/2003WO2003089641A2 Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
09/04/2003WO2003073238A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
09/04/2003WO2003073107A2 Neuropeptide receptor and uses thereof
09/04/2003WO2003073098A1 Method of screening psychotropic
09/04/2003WO2003073067A2 Rna detection enzymes
09/04/2003WO2003073062A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/04/2003WO2003072832A1 Method of error reduction in nucleic acid populations
09/04/2003WO2003072831A1 Surface modification, linker attachment, and polymerization methods
09/04/2003WO2003072829A1 Nanostructures containing pna joining or functional elements
09/04/2003WO2003072828A2 Fcgammariib polymorphisms detection in system lupus erythematosus
09/04/2003WO2003072824A1 Markers for predicting pathological conditions in haert failure and method of using the same
09/04/2003WO2003072822A2 Mononucleotide repeats microsatellite markers for detecting microsatellite instability.
09/04/2003WO2003072821A2 Method and nucleic acids for the analysis of a colon cell proliferactive disorder
09/04/2003WO2003072820A2 Method and nucleic acids for the analysis of colon cell proliferative disorders
09/04/2003WO2003072813A2 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy
09/04/2003WO2003072812A2 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
09/04/2003WO2003072811A2 The use of ribozymes in the detection of adventitious agents
09/04/2003WO2003072810A1 Headloop dna amplification
09/04/2003WO2003072809A1 Melting temperature dependent dna amplification
09/04/2003WO2003072805A2 Recombinase polymerase amplification
09/04/2003WO2003072804A2 Nanostructures containing pilin protein
09/04/2003WO2003072803A2 Nanostructures containing antibody assembly units
09/04/2003WO2003072797A1 Novel trans-viral vectors comprising multicistronic expression constructs and methods of use
09/04/2003WO2003072792A2 A method of selectively producing male or female sterile plants
09/04/2003WO2003072791A2 Transgenic fodder plants with an increased leaf starch content
09/04/2003WO2003072790A2 Production of dadzein in transgenic plants
09/04/2003WO2003072789A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003WO2003072788A1 Methods and compositions for reversibly controlling expression of target genes in cells
09/04/2003WO2003072787A2 Method for detection of leptin receptor ligands
09/04/2003WO2003072786A1 Process for producing l-threonine with the use of bacterium beloniging to the genus escherichia
09/04/2003WO2003072785A2 Fermentation process